La Jolla Bioengineering Institute, CA, USA.
Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H1062-71. doi: 10.1152/ajpheart.01022.2009. Epub 2010 Jan 8.
Hemoglobin (Hb)-based O(2) carriers (HBOCs) constitute a class of therapeutic agents designed to correct the O(2) deficit under conditions of anemia and traumatic blood loss. The O(2) transport capacity of ultrahigh-molecular-weight bovine Hb polymers (PolybHb), polymerized in the tense (T) state and relaxed (R) state, were investigated in the hamster chamber window model using microvascular measurements to determine O(2) delivery during extreme anemia. The anemic state was induced by hemodilution with a plasma expander (70-kDa dextran). After an initial moderate hemodilution to 18% hematocrit, animals were randomly assigned to exchange transfusion groups based on the type of PolybHb solution used (namely, T-state PolybHb and R-state PolybHb groups). Measurements of systemic parameters, microvascular hemodynamics, capillary perfusion, and intravascular and tissue O(2) levels were performed at 11% hematocrit. Both PolybHbs were infused at 10 g/dl, and their viscosities were higher than nondiluted blood. Restitution of the O(2) carrying capacity with T-state PolybHb exhibited lower arterial pressure and higher functional capillary density compared with R-state PolybHb. Central arterial O(2) tensions increased significantly for R-state PolybHb compared with T-state PolybHb; conversely, microvascular O(2) tensions were higher for T-state PolybHb compared with R-state PolybHb. The increased tissue Po(2) attained with T-state PolybHb results from the larger amount of O(2) released from the PolybHb and maintenance of macrovascular and microvascular hemodynamics compared with R-state PolybHb. These results suggest that the extreme high O(2) affinity of R-state PolybHb prevented O(2) bound to PolybHb from been used by the tissues. The results presented here show that T-state PolybHb, a high-viscosity O(2) carrier, is a quintessential example of an appropriately engineered O(2) carrying solution, which preserves vascular mechanical stimuli (shear stress) lost during anemic conditions and reinstates oxygenation, without the hypertensive or vasoconstriction responses observed in previous generations of HBOCs.
血红蛋白(Hb)为基础的氧载体(HBOCs)构成了一类治疗剂,旨在纠正贫血和创伤性失血情况下的氧(O2)缺乏。在仓鼠室窗模型中,使用微血管测量法研究了超高分子量牛血红蛋白聚合物(PolybHb)的 O2 运输能力,这些聚合物在紧张(T)态和松弛(R)态下聚合,以确定极度贫血期间的 O2 输送。通过用血浆扩张剂(70kDa 右旋糖酐)进行血液稀释来诱导贫血状态。在初始中等血液稀释至 18%的血细胞比容后,根据使用的 PolybHb 溶液的类型(即 T 态 PolybHb 和 R 态 PolybHb 组)将动物随机分配到交换输血组。在 11%的血细胞比容下测量全身参数、微血管血液动力学、毛细血管灌注以及血管内和组织 O2 水平。将两种 PolybHb 均以 10g/dl 的剂量输注,其粘度高于未稀释的血液。与 R 态 PolybHb 相比,T 态 PolybHb 的 O2 携带能力恢复表现出较低的动脉压和较高的功能性毛细血管密度。与 T 态 PolybHb 相比,R 态 PolybHb 导致中央动脉 O2 张力显著增加;相反,T 态 PolybHb 的微血管 O2 张力高于 R 态 PolybHb。与 R 态 PolybHb 相比,T 态 PolybHb 增加的组织 Po2 是由于从 PolybHb 中释放出更多的 O2 以及维持大血管和微血管血液动力学所致。这些结果表明,R 态 PolybHb 的极高 O2 亲和力阻止了组织利用与 PolybHb 结合的 O2。这里呈现的结果表明,T 态 PolybHb,一种高粘度的 O2 载体,是一种经过精心设计的 O2 携带溶液的典型示例,它保留了在贫血条件下丢失的血管机械刺激(剪切应力),并重新恢复氧合作用,而没有观察到前几代 HBOCs 中观察到的高血压或血管收缩反应。